SNPS Upgraded by Morgan Stanley -- Price Target Maintained at $5

Synopsys (SNPS) saw its price target raised by Needham following its investor day. The firm reportedly presented positively, with a notable announcement involving GPT-Synopsys, though details were not provided in the summary. This update may influence investor perceptions and trading activity.

Needham raised its price target on Synopsys to $620 from $580. The company's stock is currently trading at $509.99, with a 5-day change of +2.46% and a year-to-date change of +8.57%. Synopsys is also working to comply with US export rules using Chinese models.

Synopsys (SNPS) shares have rebounded over 30% since September, driven by a $1B+ deal with Amazon (AMZN) and a partnership with OpenAI. The Amazon deal focuses on Synopsys' IP business, with royalties expected to grow. The OpenAI collaboration aims to accelerate chip development. Synopsys raised its FY2030 revenue growth outlook to mid-teens CAGR and adjusted operating margin to 50%.

Synopsys (SNPS) stock rose 28% in a month, outpacing the S&P 500, after updating growth targets and partnering with OpenAI. Q3 2026 revenue grew 8.5% for chip design tools, with total revenue at $2.477B, including $711M from Ansys. Management expects double-digit growth in Q4, driven by AI demand. Operating margin is 11.0%, below the S&P 500's 18.5%, with $10B in debt. Cash flow forecast raised to $2.8B, and $1B stock buyback announced.

Synopsys (SNPS) has initiated a $1 billion accelerated share repurchase agreement with JPMorgan Chase. The deal includes an initial delivery of 1.735 million shares, with the remainder to be settled by January 5, 2027. The final share count will be based on the average daily share price during the repurchase period, minus a discount.

Argus raised its price target for Synopsys (SNPS) to $571.00. The company provides electronic design automation software and intellectual property products, which aid in chip design. This update reflects an analyst's view on the company's potential.